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Abstract
Background
Right ventricular (RV) dysfunction has been associated with poor prognosis in chronic heart
failure (HF). However, less data is available about the role of RV dysfunction in patients with
cardiac resynchronization therapy (CRT). We aimed to investigate if RV dysfunction would
predict outcome in CRT.
Design
We enrolled prospectively ninety-three consecutive HF patients in this single center obser-
vational study. All patients underwent clinical evaluation and echocardiography before CRT
and 6 months after implantation. We assessed RV geometry and function by using speckle
tracking imaging and calculated strain parameters. We performed multivariable Cox regres-
sion models to test mortality at 6 months and at 24 months.
Results
RV dysfunction, characterized by decreased RVGLS (RV global longitudinal strain) [10.2
(7.0–12.8) vs. 19.5 (15.0–23.9) %, p<0.0001] and RVFWS (RV free wall strain) [15.6 (10.0–
19.3) vs. 17.4 (10.5–22.2) %, p = 0.04], improved 6 months after CRT implantation. Increas-
ing baseline RVGLS and RVFWS predicted survival independent of other parameters at 6
months [hazard ratio (HR) = 0.37 (0.15–0.90), p = 0.02 and HR = 0.42 (0.19–0.89), p = 0.02;
per 1 standard deviation increase, respectively]. RVGLS proved to be a significant indepen-
dent predictor of mortality at 24 months [HR = 0.53 (0.32–0.86), p = 0.01], and RVFWS
showed a strong tendency [HR = 0.64 (0.40–1.00), p = 0.05]. The 24-month survival was
significantly impaired in patients with RVGLS below 10.04% before CRT implantation [area
under the curve = 0.72 (0.60–0.84), p = 0.002, log-rank p = 0.0008; HR = 5.23 (1.76–15.48),
p = 0.003].
PLOS ONE | DOI:10.1371/journal.pone.0143907 December 23, 2015 1 / 11
OPEN ACCESS
Citation: Nagy VK, Széplaki G, Apor A, Kutyifa V,
Kovács A, Kosztin A, et al. (2015) Role of Right
Ventricular Global Longitudinal Strain in Predicting
Early and Long-Term Mortality in Cardiac
Resynchronization Therapy Patients. PLoS ONE 10
(12): e0143907. doi:10.1371/journal.pone.0143907
Editor: Claudio Passino, Fondazione G. Monasterio,
ITALY
Received: July 1, 2015
Accepted: November 11, 2015
Published: December 23, 2015
Copyright: © 2015 Nagy et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by Hungarian
Foundation Programs: János Bolyai Research
Scholarship of the Hungarian Academy of Sciences
(GSZ, LG) and the Hungarian Scientific Research
Foundation (OTKA 105555). The funders had no role
in study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Conclusions
Our findings indicate that baseline RV dysfunction is associated with poor short-term and
long-term prognosis after CRT implantation.
Introduction
The prevalence of chronic heart failure (HF) increases and despite modern therapy, mortality
is high, which causes enormous economic burden to the society [1]. Cardiac resynchronisation
therapy (CRT) is effective in patients with drug refractory, advanced heart failure by reducing
mortality and improving left ventricular systolic function, and quality of life [2, 3]. Still, 20–
30% of patients do not respond to CRT as adequately as would be expected [4]. Therefore,
identifying patients who would not benefit from CRT is a burning issue.
Previous studies have shown that right ventricular (RV) dysfunction, besides left ventricular
impairment, is an important prognostic factor in patients with moderate to severe chronic
heart failure [5, 6]. However, the role of RV function in CRT patients has not been fully evalu-
ated [7, 8].
Even though echocardiography is the fundamental method for diagnosis establishment and
prognosis evaluation in HF, RV function is infrequently evaluated, due to the relative complex-
ity of right heart morphology and function. A possible solution would be speckle tracking anal-
ysis, which quantifies both global and regional wall motion and deformation in a way that is
relatively unaffected by cardiac translational motion and tethering [9].
To this aim, we investigated if baseline RV function assessed by speckle tracking imaging
would predict the short- and long-term mortality of chronic heart failure patients undergoing
CRT.
Methods
Study population
A cohort of 131 consecutive, chronic HF patients with CRT indication were enrolled between
September 2009 and December 2010 to our prospective, single-centre observational study. In
accordance with the current and recent guidelines, the inclusion criteria included: symptomatic
heart failure [New York Heart Association (NYHA) II-IVa functional class] treated with maxi-
mal tolerated medical therapy for at least 3 months prior to inclusion; LV ejection fraction
(LVEF) below 35%; QRS duration wider than 120 ms (measured on surface electrocardiogram
using the widest QRS complex from II, V1 and V6 leads) [10–13]. Exclusion criteria were
malignancies, diagnosed inflammatory diseases and primary genetic cardiomyopathies. All
patients provided their written informed consent. The study adhered to the Declaration of Hel-
sinki and was approved by the local ethics committee of the Semmelweis University.
The present echocardiographic sub-study included 93 patients, who consented to undergo
detailed echocardiographic examination (S1 Dataset).
Study protocol and outcomes
Prior to CRT implantation, at the baseline visit we examined the physical status of the patients,
recorded medical history and performed ECG analysis and detailed echocardiography. At 6
months follow-up we carried out echocardiography and clinical status assessment. Twenty-
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four months after CRT implantation we evaluated clinical status. The primary end-point of the
study was all-cause mortality at the 6 as well as the 24 months follow-up.
Device implantation
All patients underwent successful CRT-P (pacemaker only CRT) or CRT-D (CRT with
implantable cardioverter defibrillator) implantation. The right atrial and right ventricular leads
were positioned in the right appendage and mid interventricular septum or in the RV apex.
Left ventricular lead positioning was performed under guidance of venography, and when
accessible lateral or postero-lateral cardiac veins were chosen. Implanted devices included Con-
tak Renewal (Guidant Corp., Arden Hills, MN, USA), Cognis (Boston Scientific USA), Stratos,
Lumax (Biotronik, Berlin, Germany) and Insync III (Medtronic Inc., Minneapolis, MN, USA).
We implanted CRT-Ds to 46% of the patients. CRT-D was indicated in case of those patients
who suffered previously documented ventricular arrhythmias and whenever it was indicated
by the referring physician [14].
Echocardiography and Strain Imaging
We performed transthoracic echocardiography with a commercially available cardiovascular
ultrasound system (iE33, Philips Healthcare, Best, The Netherlands) and used S5-1 transducer
(Philips Healthcare, Best, The Netherlands) for the 2D and Doppler imaging. Standard para-
sternal short-, long-axis and apical views were acquired in left lateral supine position. We
repeated all measurements three times in separate cardiac cycles and calculated the average
value of the results for further analysis.
We assessed left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic
volume (LVESV), LVEF and left atrial volume (LAV) using the modified Simpson’s biplane
method. Wall motion abnormalities were detected in ischaemic patients using a model that
divides the left ventricle into 5 segments (septal, lateral, anterior, inferior, and apical) and aki-
netic wall segment abnormalities were considered for further analysis.
Guidelines proposed by the American College of Echocardiography were used to evaluate
right ventricular dimensions and function [15]. Right atrial (RA) area measurement was per-
formed using planimetry, and RA volume was calculated using the modified Simpson’s
method. We traced the endocardial borders of RV end-diastolic and end-systolic areas
(RVEDA, RVESA) manually and defined right ventricular fractional area change (RVFAC) by
using the [(RVEDA—RVESA)/RVEDA x 100] formula. The base-to-apex shortening of the
RV during systole was represented by tricuspid annular plane systolic excursion (TAPSE),
which was recorded on M-mode, guided by two-dimensional (2D) echocardiography.
We determined semiquantitatively both mitral (MI) and tricuspid insufficiency (TI) on a 4
point scale based on the maximal distance of regurgitant jet originating from the valve orifice.
Pulmonary artery systolic pressure (PASP) was evaluated using continuous wave (CW) Dopp-
ler measurement of maximal transtricuspid regurgitant flow velocity. Left ventricular diastolic
function was characterised by the mitral inflow pattern using pulsed-wave (PW) Doppler: peak
velocities of E wave [with deceleration time (DT)] and A wave were measured, then the velocity
ratio (E/A) was calculated. We performed tissue Doppler imaging (TDI) to measure the early
(E’) diastolic annular velocity at the lateral corner of the mitral annulus. Mitral E velocity, cor-
rected for the influence of relaxation (i.e., the E/E’ ratio), was calculated to estimate left ventric-
ular filling pressure.
For RV 2D speckle tracking analysis, ECG-gated digital cine-loops were obtained from api-
cal four-chamber view with a frame rate between 60 and 100 frames/sec. We achieved a better
visualisation of the right ventricle with an off-axis apical four-chamber view. Special care was
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taken to obtain the best visualisation of the whole RV for a more precise delineation of the
endocardial borders.
Off-line analysis of the acquired cine-loops was performed by an independent cardiologist
expert using a commercially available software (QLab, version 9.0, Philips, Andover, MA, USA).
To assess the regional and global RV systolic function, a 7-segment RVmodel was deployed
(basal RV free wall, mid RV free wall, apical RV free wall, apex, apical septum, mid septum and
basal septum). We calculated RV global longitudinal strain (GLS) as the average value of the
peak systolic strain of the segments. RV free wall strain was generated by making the average
value of the peak systolic strains of the 3 free RV wall segments. We would like to highlight that
the strain parameters are presented as the absolute values of the measured ones for clarity and
better understanding. We excluded those RV wall segments that were impossible to track ade-
quately and in these cases we calculated strains as the average of the acquired segments [16].
Statistical analysis
A two-tailed p-value<0.05 was considered statistically significant and data analysis was carried
out by using IBM SPSS 21 (Apache Software Foundation, USA) and Graphpad Prism 6.03
(GraphPad Softwares Inc, USA).
The variables reported in this study deviated from normal distribution (analysed by Sha-
piro-Wilk test). Categorical variables are presented as event numbers and percentage, while
continuous variables are expressed as median with interquartile range. For group comparison
we used the Mann-Whitney or Wilcoxon-test for continuous variables and the Chi-squared
test for dichotomous variables. We performed receiver operating characteristics curve analysis
to define optimal cut-off values.
We set up multivariable Cox regression models in a forward stepwise way: the first model
(M1) included those variables, which were statistically significant in the univariate analysis; the
second model (M2) comprised covariates with proven relevance in chronic heart failure. Con-
tinuous variables were ranked and standardized by one standard deviation increase (Z transfor-
mation). The proportional hazard assumption for continuous covariates was tested using
Schoenfeld residuals [17].
Intra- and interobserver variability test for RV speckle tracking analysis was performed in
10 randomly selected patients using Lin correlation. All values exceeded 0.90 (intraobserver
variability: RVGLS: 0.94, RVFWS: 0.92; interobserver variability: RVGLS: 0.91, RVFWS 0.90),
suggesting good reliability and replicability.
Results
Baseline clinical characteristics
The baseline clinical characteristics of the 93 patients are shown in Table 1. The median age
was 67 (60–72) years, the majority were male (78%) and half of the patients (49%) presented
with heart failure of ischemic origin. Ninety percent of the patients showed left bundle branch
block (LBBB) in ECG.
In our population, shorter QRS duration predicted death 6 months (n = 9) and 24 months
(n = 22) after CRT implantation and the lack of beta-blocker (BB) and aldosterone antagonist
(AA) intake was associated with poor 6 months prognosis (Table 1).
Left-side echocardiographic parameters
We observed reduced LVEF, marked left ventricular and left atrial dilatation in our patients
with moderate mitral regurgitation, as shown in Table 2. As the result of cardiac
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resynchronization, a significant improvement was seen in LVEF [29.7 (24.2–32.7) vs. 39.4
(32.3–44.7) %, p<0.0001] 6 months after implantation that was characterized by remarkable
reduction in the LVEDV [238.7 (185.2–293.9) vs. 211.5 (159.4–255.4) ml, p<0.0001) and
Table 1. Patient baseline clinical characteristics and univariate Cox regression analysis for prediction of mortality at 6 and 24months after CRT-
implantation.
mortality at 6 months mortality at 24 months
Total cohort HR 95% CI χ2 p HR 95% CI χ2 p
Age (years) 67 (60–72) 1.25 0.58–2.66 0.34 0.55 1.07 0.69–1.67 0.10 0.74
Male 72 (78%) 2.23 0.44–11.75 0.96 0.33 1.62 0.45–5.83 0.55 0.46
Ischaemic ethiology 46 (49%) 1.29 0.34–4.82 0.15 0.69 1.97 0.82–4.71 2.35 0.12
NYHA III/IV 81 (87%) 1.19 0.15–9.57 0.02 0.86 3.22 0.43–23.99 1.30 0.25
LBBB 84 (90%) 0.45 0.09–2.18 0.96 0.32 0.42 0.15–1.16 2.78 0.09
QRS-duration (ms) 160 (150–180) 0.41 0.19–0.91 4.77 0.02 0.59 0.36–0.97 4.30 0.03
CRT-D 43 (46%) 1.47 0.39–5.48 0.33 0.56 1.27 0.55–2.95 0.32 0.56
Optimal lead position 68 (73%) 1.21 0.25–5.82 0.05 0.81 1.37 0.50–3.75 0.37 0.54
Diabetes mellitus 29 (31%) 1.09 0.27–4.39 0.01 0.89 1.92 0.83–4.64 2.35 0.12
Hypertension 48 (51%) 0.45 0.11–1.81 1.24 0.26 0.62 0.26–1.46 1.16 0.28
Atrial fibrillation 26 (27%) 1.25 0.31–5.00 0.10 0.75 1.28 0.51–3.18 0.29 0.58
BB 85 (91%) 0.15 0.03–0.62 6.89 0.009 0.49 0.14–1.67 1.27 0.25
ACEi/ARB 88 (94%) 0.24 0.05–1.19 3.01 0.08 0.56 0.13–2.44 0.58 0.44
Diuretics 76 (81%) 1.79 0.22–14.31 0.30 0.58 2.15 0.50–9.28 1.07 0.30
AA 69 (74%) 0.25 0.06–0.93 4.21 0.04 1.03 0.38–2.81 0.00 0.94
Hazard ratios refer to 1 standard deviation increase in case of continuous variables and presence versus absence in case of categorical variables. HR:
hazard ratio, CI: confidence interval, χ2: wald chi square, NYHA: New York Heart Association Classification, LBBB: left bundle branch block, CRT-D:
cardiac resynchronisation therapy with defibrillator, BB: beta-blocker, ACEi/ARB: angiotensin convertase inhibitor/angiotensin receptor blocker, AA:
aldosterone antagonist, LVEF: left ventricular ejection fraction, LVEDV: left ventricular end-diastolic volume, LVESV: left ventricular end-systolic volume,
MI: mitral insufficiency.
doi:10.1371/journal.pone.0143907.t001
Table 2. Left ventricular dimensions and function before CRT implantation and univariate Cox regression analysis in case of mortality at 6 and 24
months.
mortality at 6 months mortality at 24 months
Total cohort HR 95% CI χ2 p HR 95% CI χ2 p
LVEF (%) 29.7 (24.2–32.7) 1.08 0.54–2.13 0.05 0.82 0.83 0.55–1.26 0.71 0.39
LVEDV (ml) 238.7 (185.2–293.9) 0.67 0.31–1.42 1.07 0.30 0.69 0.43–1.11 2.31 0.12
LVESV (ml) 173.8 (135.5–217.1) 0.73 0.34–1.55 0.66 0.41 0.77 0.48–1.23 1.14 0.28
LAV (ml) 95.5 (71.2–121.9) 1.41 0.80–2.48 1.42 0.23 1.46 1.01–2.09 4.22 0.04
MI 2.0 (1.0–2.5) 1.19 0.57–2.49 0.22 0.63 1.48 0.95–2.31 3.03 0.08
E/A 1.08 (0.73–1.76) 1.36 0.66–2.79 0.73 0.39 1.22 0.81–1.83 0.93 0.33
DT 160.0 (129.7–200.0) 0.96 0.50–1.85 0.01 0.91 0.77 0.48–1.23 1.15 0.28
E’ 8.3 (6.2–10.2) 1.08 0.54–2.14 0.04 0.82 0.90 0.57–1.40 0.21 0.64
E/E’ 10.6 (8.0–14.0) 0.79 0.35–1.80 0.29 0.58 1.03 0.67–1.60 0.02 0.86
Hazard ratios refer to 1 standard deviation increase in case of continuous variables and presence versus absence in case of categorical variables. HR:
hazard ratio, CI: confidence interval, χ2: wald chi square, LVEF: left ventricular ejection fraction, LVEDV: left ventricular end-diastolic volume, LVESV: left
ventricular end-systolic function, LAV: left atrial volume, MI: mitral insufficiency, E: transmitral E wave, DT: E-wave deceleration time, E’: mitral lateral
annulus tissue Doppler imaging E’ wave.
doi:10.1371/journal.pone.0143907.t002
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LVESV [173.8 (135.5–217.1) vs. 129.9 (90.1–174.5) ml, p<0.0001]. CRT also decreased LAV
[95.5 (71.2–121.9) vs. 83.1 (61.7–107.4) ml, p = 0.02], which was a significant predictor of mor-
tality at 24 months (Table 2).
Right-side echocardiographic parameters
The reduced RV function, characterized by decreased RVGLS [10.2 (7.0–12.8) vs. 19.5 (15.0–
23.9) %, p<0.0001] and RVFWS [15.6 (10.0–19.3) vs. 17.4 (10.5–22.2) %, p = 0.04], improved
6 months after CRT implantation. However, conventional RV functional parameters, RVFAC
[41.1 (30.85–51.8) vs. 42.7 (35.9–51.2) %, p = 0.74], and TAPSE [17.5 (14.0–22.0) vs. 18.2
(14.7–22.0) mm, p = 0.66] did not show statistically significant differences during the 6 months
follow-up.
The univariate Cox regression analysis revealed an overall better prognosis in patients with
increased baseline RVGLS and RVFWS, as shown in Table 3. Furthermore, patients showing
elevated baseline RVFAC and TAPSE survived the 24 months post-implant period much
better.
Multivariable analyses
In order to assess the independent effect of RV strain parameters on mortality, we set up a mul-
tivariable model (M1) adjusted to the significant clinical and left-side echocardiographic
parameters from the univariate analysis (6 months: QRS, BB and AA intake; 24 months: QRS,
LAV), as shown in Table 4.
Increasing baseline RVGLS and RVFWS values predicted survival independent of other
parameters at 6 months [hazard ratio (HR) = 0.37 (0.15–0.90), p = 0.02 and HR = 0.42 (0.19–
0.89), p = 0.02; per 1 standard deviation increase respectively].
RVGLS proved to be a significant independent predictor of the 24 months mortality
[HR = 0.53 (0.32–0.86), p = 0.01], and RVFWS showed a strong tendency [HR = 0.64 (0.40–
Table 3. Baseline RVmorphological and functional parameters predictive of 6 months and 24monthsmortality during univariate Cox regression
analysis.
mortality at 6 months mortality at 24 months
Total cohort HR 95% CI χ2 p HR 95% CI χ2 p
RVTD (mm) 36.0 (32.0–43.0) 1.35 0.73–2.46 0.94 0.33 1.34 0.90–1.99 2.11 0.14
RA area (cm2) 21.3 (17.4–28.3) 1.03 0.54–1.97 0.01 0.91 1.38 0.95–2.01 2.91 0.08
RAV (ml) 68.6 (48.8–101.7) 0.96 0.49–1.88 0.01 0.91 1.34 0.94–1.91 2.72 0.09
RVEDA (cm2) 22.5 (18.2–27.8) 1.22 0.67–2.21 0.42 0.51 1.20 0.80–1.79 0.84 0.35
RVESA (cm2) 13.1 (9.1–17.3) 1.39 0.80–2.41 1.37 0.24 1.42 0.99–2.04 3.76 0.05
RVFAC (%) 41.1 (30.85–51.8) 0.55 0.28–1.08 2.97 0.08 0.54 0.35–0.83 7.72 0.005
TAPSE (mm) 17.5 (14.0–22.0) 0.60 0.27–1.36 1.46 0.22 0.53 0.33–0.86 6.53 0.01
TI 1.0 (0.5–2.0) 1.15 0.56–2.36 0.16 0.68 1.45 0.98–2.15 3.46 0.06
PASP (Hgmm) 27.2 (20.9–37.0) 1.25 0.67–2.33 0.51 0.47 1.27 0.87–1.85 1.58 0.20
RVGLS (%) 10.2 (7.0–12.8) 0.46 0.22–0.95 4.41 0.036 0.50 0.32–0.79 8.85 0.003
RVFWS (%) 15.6 (10.0–19.3) 0.470 0.24–0.93 4.70 0.030 0.58 0.38–0.88 6.56 0.01
Hazard ratios refer to 1 standard deviation increase. HR: hazard ratio, CI: confidence interval, χ2: wald chi square, OR: odds ratio, RVTD: right ventricular
transversal diameter, RAV: right atrial volume, RVEDA: right ventricular end-diastolic area, RVESA: right ventricular end-systolic area, RVFAC: right
ventricular fractional area change, TAPSE: tricuspid annular plane systolic excursion, TI: tricuspid insufficiency, PASP: pulmonary artery systolic pressure,
RVGLS: right ventricular global longitudinal strain, RVFWS: right ventricular free wall strain.
doi:10.1371/journal.pone.0143907.t003
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1.00), p = 0.05]. RVFAC [HR = 0.67 (0.42–1.06), p = 0.09] failed to predict mortality at 24
months, TAPSE remained statistically significant [HR = 0.58 (0.35–0.96), p = 0.03].
In the second multivariable model (M2) we included the potential influential clinical covari-
ates according to current ESC guidelines (NYHA class III/IV; QRS duration, LBBB; and medi-
cal treatment: BB, ACEi/ARB and AA intake). In this model, RVGLS predicted the 24 months
mortality [HR = 0.55 (0.33–0.91), p = 0.01], but RVFWS did not [HR = 0.63 (0.40–1.00),
p = 0.05], as shown in Table 5.
The 24-months survival was significantly impaired in patients with RVGLS below 10.04%
before CRT implantation [area under the curve = 0.72 (0.60–0.84), p = 0.002, sensitivity: 77
(54–92) %, specificity: 60 (48–71) %; log-rank p = 0.0008; HR = 5.23 (1.76–15.48), p = 0.003],
as shown in Fig 1.
Discussion
Synopsis of the key findings
Our study revealed that CRT improved right ventricular dysfunction by increasing RVGLS
and RVFWS. Decreased baseline RVGLS was associated with poor short-term and long-term
prognosis independent of other parameters, RVFWS showed only a tendency for mortality pre-
diction. RVGLS below 10.04% before CRT implantation was associated with a 5-fold increased
Table 4. Multivariable Cox regression analysis of right ventricular functional parameters predictingmortality at 6 and 24months. Model 1 (M1):
those baseline clinical parameters were put in as co-variates, which were predictive of mortality during univariate analysis.
M1
mortality at 6 months mortality at 24 months
HR 95% CI χ2 p HR 95% CI χ2 p
RVGLS 0.37 0.15–0.90 4.74 0.02 RVGLS 0.53 0.32–0.86 6.58 0.01
RVFWS 0.42 0.19–0.89 5.05 0.02 RVFWS 0.64 0.40–1.00 3.70 0.054
RVFAC 0.67 0.42–1.06 2.84 0.09
TAPSE 0.58 0.35–0.96 4.42 0.03
Hazard ratios refer to 1 standard deviation increase. Models were adjusted for QRS duration, intake of beta blocker and aldosterone antagonist in case of
mortality at 6 months and QRS duration and left atrial volume in case of mortality at 24 months. HR: hazard ratio, CI: confidence interval, χ2: wald chi
square, OR: odds ratio, RVGLS: right ventricular global longitudinal strain.
doi:10.1371/journal.pone.0143907.t004
Table 5. Multivariable Cox regression analysis of right ventricular functional parameters predictingmortality at 6 and 24months. Model 2 (M2):
covariates were selected based on current CRT guidelines.
M2
mortality at 6 months mortality at 24 months
HR 95% CI χ2 p HR 95% CI χ2 p
RVGLS 0.29 0.07–1.15 3.09 0.07 RVGLS 0.55 0.33–0.91 5.25 0.02
RVFWS 0.26 0.07–0.96 4.06 0.04 RVFWS 0.63 0.40–1.00 3.84 0.050
RVFAC 0.63 0.39–1.03 3.27 0.07
TAPSE 0.63 0.37–1.05 3.04 0.08
Hazard ratios refer to 1 standard deviation increase. Models were adjusted for the following covariates: NYHA II/III stadium, QRS duration, LBBB
morphology, beta blocker, ACE inhibitor/ ARB and aldosterone antagonist intake. HR: hazard ratio, CI: confidence interval, χ2: wald chi square, OR: odds
ratio, RVGLS: right ventricular global longitudinal strain.
doi:10.1371/journal.pone.0143907.t005
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risk of 24-months mortality Conventional RV parameters, TAPSE and RVFAC affected prog-
nosis moderately and changed in a statistically indifferent manner over time.
Possible mechanisms and explanations
Right ventricular dysfunction has been associated with advanced heart failure. However, only
few studies have investigated the effect of RV function in CRT implanted patients. The com-
plex shape and volume dependency of the RV make it difficult to quantify RV morphology and
function accurately using standard echocardiography. As a result, cardiac magnetic resonance
(cMR) imaging has become the gold standard method to assess the RV [18].
The use of conventional 2D echocardiography (as a widely available and easy to obtain
imaging method) remains a clinical challenge for the assessment of RV function, however
TAPSE is still considered capable of quantifying RV longitudinal function [19]. A retrospec-
tive analysis of 848 CRT recipients demonstrated that after a median follow-up of 44 months,
TAPSE  14mm was an independent predictor of all-cause mortality [7]. Similarly, a sub-
study of the Cardiac Resynchronisation-Heart Failure (CARE-HF) trial investigated RV
function in 688 patients, of whom 345 were assigned to CRT and lower TAPSE values were
associated with higher mortality [20]. In our study, we were able to confirm these results. On
the other hand, TAPSE represents only one aspect of the complex RV function and is
strongly influenced by the overall heart motion and loading conditions as well as technical
challenges. This could be the main reason why we measured statistically indifferent TAPSE
values during the 6 months follow-up, despite the obvious changes of the RV strain
parameters.
As a result of the inherent limitations of the TAPSE measurement, other indices of RV per-
formance have been developed. For instance, in a small investigation of 77 CRT patients, the
baseline RV myocardial performance index (RVMPI), (calculated as the ratio of isovolumetric
contraction and relaxation times to ejection time) was associated with higher mortality and
heart transplantation rate [21]. Similarly, Vizzardi et al. followed-up 93 CRT patients with
moderate heart failure for five years and found that RV MPI predicts all-cause mortality and
HF hospitalisation [19]. Another interesting parameter, the RV fractional area change
(RVFAC) was also tested as a prognostic marker. Cameli et al. in 41 patients referred to heart
transplantation found RVFAC to be an independent predictor of outcome [16]. Furthermore,
in a retrospective analysis of the MADIT-CRT trial, every 5% increase in RVFAC was associ-
ated with 22% reduction in event rates and the lowest mortality rate was observed in patients
who showed the best RV function at 1-year follow-up [22]. We also found lower RVFAC values
in patients who died before 24 months, however RVFAC was not significantly influenced by
CRT, suggesting the same problem that occurred with TAPSE measurement.
Fig 1. Receiver operating characteristics analysis and Kaplan-Meyer survival curves of patients with right ventricular global longitudinal strain
below and above 10.04%.
doi:10.1371/journal.pone.0143907.g001
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Nevertheless, a non-Doppler two-dimensional echocardiographic technology, the speckle
tracking imaging has recently appeared, allowing for the quantification of global and regional
deformations. As the RV myocardium is composed of mainly longitudinal fibres, (which are
responsible for longitudinal shortenings occurring in the ejection period), the RV global longi-
tudinal strain might be a promising non-invasive parameter to quantify RV function. In agree-
ment with this, Cameli et al. investigated 41 patients before heart transplantation and RVGLS
was found to be an independent predictor of outcome [16]. Furthermore, a recent study of
Sade et al. followed up 120 patients after CRT implantation for a period of 5 years and deter-
mined RV function by using TAPSE, RVFAC, RVGLS and RVFWS. In accordance with our
data, these authors found that RV dysfunction, defined as RVFWS< 18%, independently pre-
dicted long-term mortality with high specificity and sensitivity [8].
In our analysis we used an RVGLS cut-off value of 10.04%, which indicates that patients
with slightly reduced RV function may also benefit from CRT implantation. Moreover, our
study is the first to demonstrate that baseline RV function has prognostic relevance in predict-
ing short-term mortality, and we found that patients with severely reduced RV function would
not gain survival benefit from implanted CRT. Our study also suggests that RV speckle track-
ing imaging would be a better option to characterize RV dysfunction as compared with con-
ventional methods.
It should therefore be important to precisely identify patients with RV dysfunction using
the best modalities, since these patients not only have an elevated mortality risk, but are also
more probably exposed to unnecessary surgical risks. On the other hand, a CRT implantation
causes pointless increase in healthcare costs, when more effective therapies may allow better
allocation of appropriate resources for the management of chronic heart failure.
Limitations
Our study was a single centre, observational study with relatively low sample size and inherent
limitations. First, since strain imaging highly depends on frame rate and image resolution, endo-
cardial border tracing had to be performed manually. Second, as dedicated software for RV 2D
strain was not available, thus we used a scheme designed for speckle tracking of the LV. Third,
we obtained our data from apical 4 chamber view, as this was the only image plane for longitudi-
nal RV deformation. Our echocardiographic protocol did not include 3D acquisitions, therefore,
data on RV volumes and ejection fraction could not be acquired. Furthermore, RV diastolic func-
tion analysis was not performed. In addition, the RV strain might also be influenced by loading
conditions, although in a lesser manner than by conventional RVmeasurements. Based on the
above, our study was unable to include all relevant factors affecting the outcome of CRT, i.e. labo-
ratory parameters such as NT-proBNP, which may have an effect on the results.
In view of these limitations, the presented results should be considered as being preliminary
and hypothesis-generating, and future studies should be conducted in order to confirm our
results. Despite these limitations, we believe our findings might be of remarkable clinical
interest.
Conclusion
Our analysis revealed that baseline RV dysfunction, characterized by strain parameters, is asso-
ciated with poor prognosis after CRT implantation.
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